|
GTF2E2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93101090673053E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.54354348483821E-12 |
| Normal-vs-Stage2 |
5.880400E-02 |
| Normal-vs-Stage3 |
2.0776000031475E-08 |
| Normal-vs-Stage4 |
3.3670000121333E-09 |
| Stage1-vs-Stage2 |
1.147670E-02 |
| Stage1-vs-Stage3 |
6.365000E-01 |
| Stage1-vs-Stage4 |
2.588000E-01 |
| Stage2-vs-Stage3 |
3.746300E-02 |
| Stage2-vs-Stage4 |
3.423800E-03 |
| Stage3-vs-Stage4 |
1.429240E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.7690072457176E-12 |
| Normal-vs-AfricanAmerican |
4.27689999999981E-05 |
| Normal-vs-Asian |
1.25029999686888E-08 |
| Caucasian-vs-AfricanAmerican |
1.797960E-01 |
| Caucasian-vs-Asian |
7.656800E-01 |
| AfricanAmerican-vs-Asian |
2.996400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.44399999957301E-07 |
| Normal-vs-Female |
1.25655041927075E-12 |
| Male-vs-Female |
4.011400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.84972045960785E-12 |
| Normal-vs-Age(41-60Yrs) |
1.85329973589887E-10 |
| Normal-vs-Age(61-80Yrs) |
8.48530000000514E-05 |
| Normal-vs-Age(81-100Yrs) |
3.945600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.167800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.386410E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.547800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.412100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.073040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.378000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.151900E-02 |
| Classical-VS-Follicular |
5.89969999520434E-08 |
| Classical-VS-Other |
9.561200E-01 |
| Classical-VS-Normal |
1.626032641866E-12 |
| Tall-VS-Follicular |
3.07539999999662E-06 |
| Tall-VS-Other |
3.821200E-01 |
| Tall-VS-Normal |
1.19649999907878E-08 |
| Follicular-VS-Other |
9.481900E-02 |
| Follicular-VS-Normal |
2.940400E-01 |
| Other-VS-Normal |
7.892100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.60579999994604E-06 |
| Normal-vs-N1 |
5.59799999999555E-05 |
| N0-vs-N1 |
3.683800E-01 |
|
|
